Research programme: monoclonal antibodies - Janssen Biotech
Latest Information Update: 31 Mar 2023
At a glance
- Originator Janssen Biotech
- Class Monoclonal antibodies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Unspecified